ER is still recruited to chromatin in tamoxifen-resistant breast cancer, further binds to the HOTAIR promoter region and enhances transcription of the HOTAIR gene, thus promoting breast cancer growth. This evidence concerns the gene ESR1 and breast carcinoma.